Localization of lipoprotein(a) in a monkey model of rapid neointimal growth

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 1, 1997, Pages 181-187

  Ryan, Michael J ^a   Emig, Laura L ^a   Hicks, Gary W ^a   Ramharack, Randy ^a   Spahr, Mark A ^a   Kreick, Jeffrey S ^a   Brammer, David W ^a   Chien, Alexander J ^a   Keiser, Joan A ^a  

^a PFIZER INC   (United States)

Author keywords

lipoprotein(a); neointimal growth; nonhuman primate; restenosis

Indexed keywords

LIPOPROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ILIAC ARTERY; INTIMA; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTENOSIS; RISK FACTOR; THROMBOGENESIS;

EID: 0031037551     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.1.181     Document Type: Article

References (26)

1. Scanu AM. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA. 1992;267:3326-3329.
2. Hearn J, Donohue B, Ba'albaki H, Douglas JS, King SB, Lembo NJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69:736-739.
3. Tenda K, Saikawa T, Maeda T, Sato Y, Niwa H, Inoue T, Yonemochi H, Maruyama T, Shimoyama N, Aragaki S, Hara M, Takaki R. The relationship between serum lipoprotein (a) and restenosis after initial elective percutaneous transluminal coronary angioplasty. Jpn Circ J. 1993;57:789-795.
4. Daida H, Lee YJ, Yokoi H, Kanoh T, Ishiwata S, Kalo K, Nishikawa H, Takatsu F, Kato H, Kutsumi Y, Yamada N, Noma A, Yamaguchi H. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein(a) levels with low-density lipoprotein apheresis. Am J Cardiol. 1994;73:1037-1040.
5. Donohue B, Lasorda D, Barker E, Begg R, Vido D, Ergina R, Incorvati D, Farah T, Sgoutas D. Lp(a) correlates with restenosis after PTCA. J Am Coll Cardiol. 1993;21:1-33A. Abstract.
6. Desmarais RL, Sarembock IJ, Ayers CR, Vernon SM, Powers ER, Gimple LW. Elevated serum lipoprotein(a) level is a risk factor for clinical recurrence after coronary balloon angioplasty. Circulation. 1995:91:1403-1409.
7. Shah PK, Amin J. Low high-density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992;85:1283-1288.
8. Cooke T, Sheahan R, Foley D, Reilly M, D'Arcy G, Jauch W, Gibney M, Gearty G, Crean P, Walsh M. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Circulation. 1994;89:1593-1598.
9. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker LA. Effects of angiotensin converting enzyme inhibition with cilazapril on intimai hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991;18(suppl II):II-70-II-76.
10. Williams JK, Bellinger DA, Nichols TC, Griggs TR, Bumol TF, Fouts RL, Clarkson TB. Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a). Arterioscler Thromb. 1993;13:548-459.
11. Rath M, Niendorf A, Reblin T, Dietel M, Krebber H, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
12. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TMA, Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at reoperation. Arteriosclerosis. 1989;9:593-603.
13. Grainger D, Kirschenlohr H, Metcalfe J, Weissberg P, Wade D, Lawn R. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science. 1993;260:1655-1658.
14. Kojima S, Harpel P, Rifkin D. Lipoprotein (a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle migration. J Cell Biol. 1991;113:1439-1445.
15. Taddei-Peters WC, Butman BT, Jones GR, Venetta TM, Macomber PF, Ransom JH. Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay. Clin Chem. 1993;39:1382-1389.
16. Liu AC, Lawn RM. Lipoprotein(a) and atherogenesis. Trends Cardiovasc Med. 1994;4:40-44.
17. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG. Rubin EM. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature. 1992;360:670-672.
18. Linton MF, Farese RV, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest. 1993;92:3029-3037.
19. Callow MJ, Stoltzfus U, Lawn RM, Rubin EM. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci U S A. 1994;91:2130-2134.
20. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132-137.
21. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol. 1990;110:1361-1367.
22. Clowes AW, Reidy MA, Clowes MM. Mechanism of stenosis after arterial injury. Lab Invest. 1983;49:208-215.
23. Ezratty A, Simon DI, Loscalzo J. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry. 1993;32:4628-4633.
24. Miles LA, Hess GM, Scanu AM, Baynham P, Sebald MT, Skocir P, Curtiss LK, Levin EG, Hoover-Plow JL, Plow EF. Interaction of Lp(a) with plasminogen binding sites on cells. Thromb Haemost. 1995;73:458-465.
25. Zioncheck TF, Powell LM, Rice GC, Eaton DL, Lawn RM. Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages. J Clin Invest. 1991;87:767-771.
26. Bottalico LA, Keesler GA, Hess GM, Tabas I. Cholesterol loading of macrophages leads to marked enhancement of native lipoprotein(a) and apoprotein(a) internalization and degradation. J Biol Chem. 1993;268:8569-8573.